Think Malaria, TB, HIV/AIDS, and the latest: Ebola. Different from “Orphan” Diseases (in which the affliction occurs in developed countries, but has an extremely low prevalence), neglected and tropical diseases are mainly characteristic of underdeveloped regions. Both classifications present a conundrum to pharmaceutical companies. Conditions with very small populations, and conditions that may in fact... Read More ›![]()
